CLINICAL_TRIALS
trial_result
· 2018-11-05
Clinical Trial Update: A Study of Enzastaurin in Participants With Follicular Lymphoma [Phase 2]
Summary
Phase 2 trial update for enzastaurin in follicular lymphoma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Lymphoma, Follicular | Phase 2 | Status: COMPLETED | Results posted: 2018-11-05